SCHEMBL8216758

SCHEMBL8216758

CC1CCCc2ncncc2C1(C)C

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8084918 0.74 IDH1 (0.37) CYP11B2
SCHEMBL8097676 0.70 GRM4 (0.36)
SCHEMBL14264346 0.70 CYP11B1 (0.34) CYP11B2
SCHEMBL17729268 0.70 GRM4 (0.36)
SCHEMBL13983944 0.69 NTRK1 (0.33)
SCHEMBL9537354 0.69 NTRK1 (0.33)
SCHEMBL14425987 0.69 NTRK1 (0.33)
SCHEMBL1129532 0.67 GRM4 (0.34)
SCHEMBL12163198 0.65
SCHEMBL10297548 0.62 NTRK1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758883-B1 Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors SCHERING CORP (US) 2011-11-02 EP disclosed
WO-2008021235-A2 PROCESS AND INTERMEDIATES FOR THE SYNTHESIS OF 2-(QUINOLIN-5-YL)-4,5 DISUBSTITUTED-AZOLE DERIVATIVES SCHERING CORPORATION (US) 2008-02-21 WO disclosed